ZhongOu Fund Appoints Tech Specialist Dai Yunfeng to Succeed Ge Lan as Manager of Mingrui New Starting Fund

Deep News
04/29

On April 29, ZhongOu Fund announced that Dai Yunfeng will replace Ge Lan as the fund manager of ZhongOu Mingrui New Starting Fund. The latest quarterly report shows the fund's top ten holdings are primarily concentrated in electronics, power equipment, and telecommunications sectors. The newly appointed manager Dai Yunfeng is a member of ZhongOu Fund's technology team with 13 years of securities industry experience and 8 years in investment management, specializing in technology and manufacturing sectors. Following this change, Ge Lan will continue to manage two healthcare-themed funds: ZhongOu Healthcare and ZhongOu Healthcare Innovation. Since its inception, ZhongOu Healthcare A has achieved a return of 94.71%, compared to its benchmark return of 8.9%. ZhongOu Healthcare Innovation A has gained 44.34% since establishment, versus its benchmark's -1.29%. Market analysts note that deepening professional specialization helps fund managers focus on their core expertise and potentially enhance investment management capabilities. Recent regulatory guidelines emphasize accelerating the development of integrated, multi-strategy investment research systems and supporting team-based management approaches to strengthen research capabilities. Investment funds carry risks, and investors should exercise caution. Past performance does not guarantee future results. Investors should review legal documents and understand risk characteristics before making investment decisions. Mixed funds like ZhongOu Healthcare and ZhongOu Mingrui New Starting typically show higher risk-return profiles than bond or money market funds but lower than equity funds. Equity funds such as ZhongOu Healthcare Innovation generally demonstrate higher risk-return characteristics than bond, money market, or mixed funds. Fee structures vary by share class and holding period, with detailed schedules provided in fund documents.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10